-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Ischemic stroke is a major risk in patients with atrial fibrillation (AF) and is the basis for patient risk stratification and consideration of anticoagulant therapy
.
This is one of the most important factors in recovery
stroke
Currently, contemporary data on stroke severity and prognosis in AF patients are lacking
.
The aim of the researchers was to investigate stroke severity and subsequent mortality in patients with and without atrial fibrillation (AF)
Blood vessel
Patients with first-time ischemic stroke from the Danish Stroke Registry (January 2005 to December 2016) were included in an observational study
.
Patients with AF were matched 1:1 with those without AF by sex, age, year, and CHA2DS2-VASc
CHA2DS2-VASc
Of the 86,458 identified stroke patients, 17,205 had AF
.
After matching, we included 14,662 patients with AF and 14,662 patients without AF (51.
CONCLUSIONS: In a contemporary national cohort of ischemic stroke patients, AF patients had more severe stroke and higher mortality compared with non-AF patients
.
Differences in mortality were mainly mediated by stroke severity
In a contemporary national cohort of ischemic stroke patients, AF patients had more severe stroke and higher mortality compared with non-AF patients
Original source:
Naja E.